HOME >> MEDICINE >> NEWS
Highlights summarized for movement disorders research at 56th annual meeting

ST. PAUL, Minn. (May 4, 2004) - Movement disorders are neurological diseases that cause aberrant movement, and include Parkinson's disease, tremor, restless legs syndrome and dystonia. Among the largest of subspecialties within neurology, they are also the subject of some of the most intense research. At the 56th Annual Meeting of the American Academy of Neurology, these were some of the highlights of new research presented in movement disorders:

Parkinson's Disease Basic Science

Parkinson's disease (PD) is caused by progressive cell death in a small part of the brain that helps control movements by releasing the chemical dopamine. Levodopa is the mainstay of PD therapy, but must be converted in the brain into dopamine by an enzyme called AADC (aromatic L-amino acid decarboxylase). Researchers in California presented results of a long-term gene therapy trial in monkeys with a condition that mimics PD. They introduced the gene for AADC into the affected parts of the brains of four monkeys, using a virus as a carrier. After three-and-a-half years, the gene was still making the enzyme widely throughout the affected part of the brain, and the monkeys required much less levodopa to control their PD symptoms. Importantly, the dose of levodopa could be lowered to the point that it no longer caused uncontrolled movements called dyskinesias, which are a major complication of late-stage PD treatment. These promising results suggest that this approach may work in PD patients as well. [S28.004]

Parkinson's Disease Genetics

Most cases of PD are thought to result from a combination of genes and environmental factors such as pesticides and other poisons. Genes that cause PD by themselves are rare. An exception is found in a pair of families from Greece and Italy, who carry a mutation in a gene for a brain protein called alpha-synuclein. While this mutation is exceedingly rare, it has already taught PD researchers much about the dise
'"/>

Contact: Kathy Stone
kstone@aan.com
651-695-2763
American Academy of Neurology
4-May-2004


Page: 1 2 3 4 5

Related medicine news :

1. Highlights of the December Journal of the American Dietetic Association
2. Highlights of the September Journal of the American Dietetic Association
3. Highlights of Washington University Alzheimers Research at National Conference
4. Highlights of June Journal of the American Dietetic Association
5. Effective Clinical Practice, Jan/Feb. 2002 Highlights
6. Study Highlights Flu Risks For Women With Chronic Illness
7. Maxim Phase II Clinical Trial Highlights Substantial Increase In Leukemia-FreeSurvival For Acute Myelogenous Leukemia Patients
8. Speakers cramp, a new type of involuntary mouth-, lip-muscle movement
9. New system for the analysis of facial movement in three dimensions
10. Rutgers-Newark researchers link early movement, brain development
11. GSKS Requip(R) (ropinirole HCl) significantly reduces periodic leg movements in patients with RLS

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that covers care ... have a waiver for care if the client has a cognitive impairment diagnosis. ... for care, is often waived, so the benefits from their insurance start immediately,” said ...
(Date:10/13/2017)... ... 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out ... free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting ... children of all ages; it is a non-competitive, non-timed event, which is all about ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Agile Software Development, has been awarded a contract by the Center for Medicare ... (BPA) aims to accelerate the enterprise use of Agile methodologies in a consistent ...
(Date:10/12/2017)... ... October 12, 2017 , ... First ... compliance program management, will showcase a range of technology and learning solutions at ... (NCAL) Convention and Expo to be held October 14–18, 2017 at the Mandalay ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company ... of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every ... meet the highest standard. , These products are also: Gluten Free, Non-GMO, ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... -- Cohen Veterans Bioscience and Early Signal Foundation announce ... home sensors for real-time monitoring of patients with trauma-related ... organization focused on disruptive health solutions for rare disorders ... to record and integrate behavioral, cognitive, physiological and contextual ... ...
(Date:9/27/2017)... , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading global ... that its MyDario product is expected to appear on The Dr. Oz ... Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz Show kicked ... The segment features ...
(Date:9/25/2017)... 2017  EpiVax, Inc., a leader in the ... today announced the launch of EpiVax Oncology Inc., ... therapeutic cancer vaccines. EpiVax has provided $500,000 in ... enabling technologies to the new precision immunotherapy venture. ... Oncology as Chief Executive Officer. Gad brings over ...
Breaking Medicine Technology:
Cached News: